Interview with Orison Huerta, Managing Director Mexico, Central America &…
Can you give us a historical overview of the main milestones and achievements of Ottobock since it settled in Mexico in 1995? Ottobock was founded in 1919 by Doctor Ottobock…
Address: Otto Bock de Mexico S.A. de C.V Prolongacion Calle 18 No. 178-A, Col. San Pedro de los Pinos, C.P. 01180 México, D.F.,Mexico
Tel: 55 5278 4160
Web: http://www.ottobock.com.mx/cps/rde/xchg/ob_lam_es/hs.xsl/14699.html
Ottobock is a modern medical company – technology oriented towards success, tradition, and a world player with local roots. Ottobock is at the forefront of innovation with distribution and services points in 44 countries and contacts to export in 140 countries.
Ottobock’s products are aimed at providing the patient more mobility: prothesis, wheel chairs, and orthosis supports.
Can you give us a historical overview of the main milestones and achievements of Ottobock since it settled in Mexico in 1995? Ottobock was founded in 1919 by Doctor Ottobock…
Juan de Villafranca, executive director of the Asociacion Mexicana de Laboratorios Farmaceuticos (AMELAF), shares the exciting new initiatives he has launched in the past two years of his term; the…
Below is a selection of top recent news from Mexican pharma and healthcare, including the healthcare reforms president Andres Manuel Lopez Obrador is prioritising, latest news on the INSABI program,…
Between 2015 and 2017 PharmaBoardroom met with pharma country managers in Mexico who spoke about the challenges and opportunities present in the Mexican market. Since then, these five stakeholders have…
The United States Trade Representative Office has been engaging with a number of countries, including Mexico, to address concerns related to IP protection and enforcement and market access barriers for…
What traits, competencies and drivers do you need to be a successful pharma country manager in today’s dynamic Mexican pharma market? Jose Guerrero and Male Mejido from the Mexico office…
Cristobal Thompson of the AMIIF examines the steps forward that Mexican pharma has made in countering corruption, the areas in which urgent improvement is still needed, and outlines the three…
Cristobal Thompson is the executive director at AMIIF (Asociacion Mexicana de Industrias de Investigacion Farmaceutica). In this article, he introduces us to an exciting new youth program set up to improve…
Cristobal Thompson is the Executive Director at AMIIF (Asociacion Mexicana de Industrias de Investigacion Farmaceutica). The AMIIF represents more than 60 global companies with the aim of contributing to improving health…
David Peña Castillo, president and founder of the Mexican Federation of Rare Diseases (FEMEXER), addresses the problem of patients deserting therapies. In Mexico, approximately 15 percent of patients treated…
Cristobal Thompson is the executive director at AMIIF (Asociacion Mexicana de Industrias de Investigacion Farmaceutica). The AMIIF represents more than 60 global companies with the aim of contributing to improving health…
Cristobal Thompson is the Executive Director at AMIIF (Asociacion Mexicana de Industrias de Investigacion Farmaceutica). The AMIIF represents more than 60 global companies with the aim of contributing to improving health…
Cristobal Thompson is the Executive Director at AMIIF (Asociacion Mexicana de Industrias de Investigacion Farmaceutica). The AMIIF represents more than 60 global companies with the aim of contributing to improving…
See our Cookie Privacy Policy Here
